IMMUNOMEDICS IMMU TO SELL COMMON STOCK NEWARK N J April Immunomedics Inc said it filed a registration statement with the Securities and Exchange Commission for the proposed sale of shares of common stock The company said it will sell shares and that certain stockholders will sell the remaining shares Proceeds from the offering will be used for product development basic research staff expansion prepayment of debt capital expenditures and working capital the company said The offering will be co managed by E F Hutton and Co Inc and First Boston Corp Immunomedics said Reuter